Most active New York Stock Exchange-traded stocks
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 4:25PM CDT
ViiV Healthcare's Triumeq approved for the treatment of HIV-1 infection in patients above 12 years and weighing at least 40kg.
Is It Time to Buy Actavis plc Stock?
George Budwell, The Motley Fool - Motley Fool - Mon Sep 08, 1:15PM CDT
By all available metrics, the healthcare sector has been performing admirably so far this year. Despite a weak second quarter, most healthcare stocks have seen their share prices climb by double digits for a third straight year. While the sector...
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 08, 1:11PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Sep 08, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig
at The Street - Mon Sep 08, 7:48AM CDT
Meacham is taking a new job at Barclays where he will cover biotech and pharma stocks.
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:12PM CDT
The Dow had a lacklustre week after weakness in energy shares and a series of other concerns dampened investor sentiment.
Novartis Offers Healthy Gains at a Bargain Stock Price
at The Street - Fri Sep 05, 5:30AM CDT
The company has a potential life-saving catalyst in its portfolio, too.
Market Maker Surveillance Report. PFE, TWX, CSCO, MDT, DEPO, QQQ, Bearishly Biased Price Friction For Thursday, September 4th 2014
M2 - Fri Sep 05, 3:10AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4751 companies with "abnormal" market making, 1909 companies with positive Friction Factors and 3133 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Pfizer Inc (NYSE
Merck PD-1 Inhibitor Approved For Skin Cancer
at Investor's Business Daily - Thu Sep 04, 3:33PM CDT
Merck's (MRK) pembrolizumab won FDA approval for melanoma Thursday afternoon, making it the first drug in the much-anticipated PD-1 inhibitor class to hit the U.S. market. Pembrolizumab, now branded Keytruda, was approved before the normal three...
Market Maker Surveillance Report. PFE, GE, CSCO, VZ, MSFT, CBS, Bearishly Biased Price Friction For Tuesday, September 2nd 2014
M2 - Thu Sep 04, 9:46AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4916 companies with "abnormal" market making, 2511 companies with positive Friction Factors and 2570 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Pfizer Inc (NYSE
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Todd Campbell, The Motley Fool - Motley Fool - Thu Sep 04, 8:41AM CDT
Bristol-Myers's Squibb and Pfizer 's Eliquis, an anticoagulant challenger to both warfarin and Johnson & Johnson 's and Bayer 's Xarelto, has seen its sales soar over the past six quarters. Eliquis, a factor Xa inhibitor used by...
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher
PR Newswire - Thu Sep 04, 8:20AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Express Scripts Holding Company (NASDAQ: ESRX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6210-100free.